Market capitalization | $7.45m |
Short interest | 4.71% |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
1 Analyst has issued a forecast Forward Pharma A/S Sponsored ADR:
1 Analyst has issued a forecast Forward Pharma A/S Sponsored ADR:
Dec '21 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | -3.87 -3.87 |
13%
13%
|
EBIT (Operating Income) EBIT | -3.87 -3.87 |
13%
13%
|
Net Profit | -1.89 -1.89 |
71%
71%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 1, 2005 and is headquartered in Copenhagen, Denmark.
Head office | Denmark |
CEO | Claus Svendsen |
Employees | 4 |
Founded | 2005 |
Website | www.forward-pharma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.